The technology about to be deployed at NT Cardiac.
Commenced preliminary discussions with potential strategic partners in the United States & Canada.
Reviewed potential acquisitions, that would compliment Alcidion Product Folio and contribute to the company’s overall profitability and accelerate the commercialisation initiatives.
Few Competitors within the independent Patient Flow, Electronic Bed Management, Clinical Decision Support Space.
Monolithic Solutions are extraordinary expensive and form part of a much broader eHealth strategy.
Trump administration demanding substantial improvements in healthcare efficiency and looking towards Information Technology Solutions to address these challenges.
Late stage negotiations with a District Health Board in New Zealand, with expectations to close in Q4 FY17.
Invested $1.5m developing a Computerized Physician Order Entry (CPOE) platform, in the form of a Best Practice Pathology Ordering product that automates the electronic ordering of pathology for ED physicians.
ALC Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)